Aclaris Therapeutics Inc (ACRS)
Healthcare
Biotechnology
5.20 $
-2.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Aclaris Therapeutics Inc (ACRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -47 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.6 | -20 | -35 | -55 | -101 | -96 | -39 | -52 | -68 | -78 | -20 | -47 | |
| 0.0 | 0.1 | 0.1 | 0.4 | 1.9 | 1.6 | 1.3 | 0.9 | 0.8 | 0.9 | 0.8 | 0.5 | |
| 0.0 | 0.9 | 6.1 | 14 | 20 | 16 | 11 | 14 | 15 | 21 | 11 | 12 | |
| 0.0 | 1.2 | 9.1 | 13 | 21 | 63 | 13 | 39 | 20 | – | – | – | |
| 0.8 | -1.1 | 4.3 | 0.9 | 9.4 | -2.7 | -2.4 | -1.3 | -1.2 | 9.4 | 11 | 2.7 | |
| 0.4 | 0.5 | 0.2 | 1.2 | 1.4 | 1.6 | 0.5 | 0.3 | 0.6 | 1.3 | 0.1 | 0.1 | |
| -1.8 | -77 | -62 | -56 | 9.4 | 106 | 6.4 | -168 | 13 | 46 | -70 | 48 | |
| – | 0.0 | 0.0 | 0.0 | – | – | 7.7 | 3.1 | – | – | – | – | |
| 63 | 96 | 117 | 100 | 101 | 0.2 | 7.7 | -3.1 | 0.0 | -0.1 | – | -0.4 | |
| -0.1 | -0.1 | -0.1 | -0.1 | 29 | -30 | 11 | -11 | 0.0 | 0.0 | – | – | |
| 11 | 96 | 117 | 100 | 128 | -30 | 18 | 225 | 73 | 27 | 75 | -5.9 | |
| 1.2 | -0.9 | 20 | -10.0 | 37 | -21 | -14 | 5.3 | 18 | -5.4 | -15 | -4.6 | |
| -8.1 | -21 | -35 | -56 | -102 | -98 | -39 | -52 | -68 | -80 | -20 | -47 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.